Rad Immune Therapeutics, Inc. reported raising $13.6 Million in an initial SEC Form D filing, from an offering of $21.8 Million
Amount Raised
$13.6 Million
Round Type
Venture
TarrytownHealthcareWho else raised in Healthcare around the same time
Companies in the same sectors as RadImmune Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Athenen Therapeutics, Inc. raised $5M on October 4, 2019.
- ACU Development, Inc. raised $2.9M (Seed) on October 4, 2019.
- RxWare raised $3.6M (Seed) on October 4, 2019.
- SiO2 Medical Products, Inc. raised $48M on October 4, 2019.
- Ocugenix Corp raised $350K (Seed) on October 4, 2019.
- Immuneering raised $20M on October 4, 2019.
Who to call at RadImmune Therapeutics, Inc., and when
A new round usually means RadImmune Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day RadImmune Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at RadImmune Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at RadImmune Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment RadImmune Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
RadImmune Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.